JNK

下级目录

GSK-2256098

Etalocib

Spisulosine

AS601245

CEP-5214

Pamapimod

SNX-7081

1,9-Pyrazoloanthrone

Miltefosine

HA14-1

Perifosine

目录项下的产品

1224887-10-8 / MFCD324887108
2-((5-Chloro-2-((1-Isopropyl-3-Methyl-1H-Pyrazol-5-Yl)Amino)Pyridin-4-Yl)Amino)-N-Methoxybenzamide
2-((5-氯-2-((1-异丙基-3-甲基-1H-吡唑-5-基)氨基)吡啶-4-基)氨基)-N-甲氧基苯甲酰胺

原料 0 ^资源 0.0^询 0.0^%成交 ^交易量
试剂

161172-51-6 / MFCD61172516
2-(3-(3-((5-Ethyl-4'-Fluoro-2-Hydroxy-[1,1'-Biphenyl]-4-Yl)Oxy)Propoxy)-2-Propylphenoxy)Benzoic Acid
2-(3-(3-((5-乙基-4'-氟-2-羟基-[1,1'-联苯]-4-基)氧基)丙氧基)-2-丙基苯氧基)苯甲酸

原料 0 ^资源 0.0^询 0.0^%成交 ^交易量
试剂

196497-48-0 / MFCD96497480
Spisulosine, also known as ES-285, is novel compound derived from the marine mollusk Spisula polynoma with evidence of preclinical antitumor activity. Phase I clinical trial results: Dose level VIII (200 mg/m(2)) was considered the MTD, and dose level IX (160 mg/m(2)) was defined as the RD. Limited antitumor activity was observed.

原料 0 ^资源 0.0^询 0.0^%成交 ^交易量
试剂

345987-15-7 / MFCD45987157
2-(benzo[d]thiazol-2-yl)-2-(2-((2-(pyridin-3-yl)ethyl)imino)-1,2-dihydropyrimidin-4-yl)acetonitrile
2-(苯并[d]噻唑-2-基)-2-(2-((2-(吡啶-3-基)乙基)亚氨基)-1,2-二氢嘧啶-4-基)乙腈

原料 0 ^资源 0.0^询 0.0^%成交 ^交易量
试剂

402857-39-0 / MFCD02857390
CEP-5214 is a potent, low-nanomolar pan inhibitor of human VEGF-R tyrosine kinases, displaying IC(50) values of 16, 8, and 4 nM for VEGF-R1/FLT-1, VEGF-R2/KDR, and VEGF-R3/FLT-4, respectively, with cellular activity equivalent to the isolated enzyme activity. Compound 21 exhibited good selectivity against numerous tyrosine and serine/threonine kinases including PKC, Tie2, TrkA, CDK1, p38, JNK, and IRK.

原料 0 ^资源 0.0^询 0.0^%成交 ^交易量
试剂

449811-01-2 / MFCD49811012
Pamapimod is a novel p38 mitogen-activated protein kinase inhibitor. Pamapimod inhibited p38alpha and p38beta enzymatic activity, with IC(50) values of 0.014 +/- 0.002 and 0.48 +/- 0.04 microM, respectively. There was no activity against p38delta or p38gamma isoforms. When profiled across 350 kinases, pamapimod bound only to four kinases in addition to p38. Cellular potency was assessed using phosphorylation of heat shock protein-27 and c-Jun as selective readouts for p38 and c-Jun NH(2)-terminal kinase (JNK), respectively. Pamapimod inhibited p38 (IC(50), 0.06 microM), but inhibition of JNK was not detected. Pamapimod also inhibited lipopolysaccharide (LPS)-stimulated tumor necrosis factor (TNF) alpha production by monocytes, interleukin (IL)-1beta production in human whole blood, and spontaneous TNFalpha production by synovial explants from RA patients. Pamapimod is a potent, selective inhibitor of p38alpha with the ability to inhibit the signs and symptoms of RA and other autoimmune
帕吡莫德

原料 0 ^资源 0.0^询 0.0^%成交 ^交易量
试剂

908111-22-8 / MFCD008111228
SNX-7081

原料 0 ^资源 0.0^询 0.0^%成交 ^交易量
试剂

129-56-6 / MFCD00022289
1,9-Pyrazoloanthrone
吡唑蒽酮

原料 0 ^资源 0.0^询 0.0^%成交 ^交易量
试剂

中华人民共和国
上海市
√
北京市
深圳市

58066-85-6 / MFCD00133396
hexadecyl (2-(trimethylammonio)ethyl) phosphate
米替福新

原料 0 ^资源 0.0^询 0.0^%成交 ^交易量
试剂

65673-63-4 / MFCD00218213
ethyl (R)-2-amino-6-bromo-4-((R)-1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate
乙基-2-氨基-6-溴-4-(1-氰基-2-乙氧基-2-甲酰)-4H-苯并呋喃-3-羧酸

原料 0 ^资源 0.0^询 0.0^%成交 ^交易量
试剂

北京市
√

157716-52-4 / MFCD00927554
1,1-Dimethylpiperidin-1-Ium-4-yl Octadecyl Phosphate
(1,1-二甲基哌啶-1--4-基)十八烷基磷酸酯

原料 0 ^资源 0.0^询 0.0^%成交 ^交易量
试剂

JNK

下级目录

目录项下的产品

Products Indices

Mailings

Contact

链接

搜索结果

JNK

下级目录

目录项下的产品

Products Indices

Mailings

Contact

链接